<?xml version="1.0" encoding="UTF-8"?>
<p>The regulatory guidelines for herbal medicines differ from country to country. USFDA classifies herbal medicines into dietary supplements and botanical drugs. Safety and efficacy studies are not needed for marketing of dietary supplements, but they should be so labeled. For botanicals, description of the product and documentation of prior human experience of the product is required. The requirements may vary from non-clinical studies to clinical trials, batch effect analysis [
 <xref rid="B262-brainsci-10-00964" ref-type="bibr">262</xref>]. In European Union, Committee on Herbal Medicinal Products (HMPC) issues scientific opinions on herbal substances and preparations [
 <xref rid="B263-brainsci-10-00964" ref-type="bibr">263</xref>]. The regulatory pathways depend on prior human exposure and range from traditional use registration; well established use marketing authorization and to stand alone or mixed application.
</p>
